Hoopcare
Techstars '25Paris, FR · Founded 2019 · 8 employees on LinkedIn · 4 known investors
Find your way into Hoopcare
Hoopcare provides HIPAA-compliant AI-powered clinical tools for healthcare professionals to extract patient data from EHRs, generate preoperative notes, and identify clinical insights. The platform is designed for U.S. healthcare professionals and aims to reduce administrative burden.
Also known as Hoop Care, Inc. · HoopCare · Hoopcare Medical of Florida P.A. · Intelligence Anesthesia
Investors · 4
How we know: Newfund Capital's portfolio page · research · wealthierlife.substack.com · Not right? Tell us
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$220K disclosed across 1 round · 2026
- $220KSeedMar 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Sep 2026Hoopcare (legal entity Hoop Care, Inc., previously known as Intelligence Anesthesia) is a medical technology company founded by physicians that develops artificial intelligence models for surgery, anesthesia and perioperative care. Its platform screens surgical patients for more than 20 outcomes and is designed to run inside Epic and Cerner environments via SMART on FHIR integration. The model catalog includes an ensemble Global Risk Score producing a 0-100 score with risk tier and drivers, prediction of required red blood cell units, ambulatory surgery center (ASC) eligibility triage, hospital and ICU length of stay and operating room time, postoperative venous thromboembolism risk, and ECG-based models for low left ventricular ejection fraction, severe aortic stenosis and pulmonary hypertension screening. Additional predictions cover pain, acute kidney injury, sepsis, pneumonia, readmission and ICU admission. The company states models were trained and validated on a de-identified cohort of more than 1.3 million surgical cases, with full metrics shared under NDA and in manuscripts in preparation; the site notes model performance and availability are pending final locked-cohort analysis and partner authorization and are not for clinical use, and that Hoopcare is not a medical device and has not been evaluated by the FDA.
The earlier product line, described in French-language company communications, centered on a digital preoperative clinic: an AI-assisted preoperative questionnaire self-completed by patients (optionally with a Hoopcare-trained medical assistant), automated organization of responses into a clinical dashboard, decision support for preoperative testing, cardiac evaluation and patient blood management, automated SMS patient engagement, a patient information center, and postoperative follow-up using questionnaires and connected watches collecting data such as heart rate and step counts. Use cases highlighted included anemia detection and management pathways, smoking cessation referral, and anesthesia teleconsultation with a fast-track route for low-risk patients.
Hoopcare operates consumer-facing information resources on surgery and anesthesia topics, and maintains both U.S. and French web properties. Affiliated entities named on the site include Hoopcare Medical of Florida P.A. and other professional entities delivering clinical care as wholly owned subsidiaries of Hoop Care Inc.
Founding story
Hoopcare was founded in 2019 by Dr. Yassine Moussali, an anesthesiologist-intensivist, and was initially known as Intelligence Anesthesia. Moussali, from Le Puy-en-Velay and from a family of anesthesiologists, studied medicine at Lyon-Est and trained in anesthesia and intensive care in Paris at AP-HP and Paris ESPIC sites, with an international rotation at Guy's and St Thomas' Hospital in London. After obtaining his replacement licence he worked locum shifts in more than forty facilities across France. His 2019 thesis on preoperative evaluation and the anesthesia consultation formed the basis of Hoopcare. He subsequently worked at Hôpital Privé Claude Galien with the Quincy Anesthésie team, where he self-funded the early company, built a prototype and ran trials at Hôpital Foch to demonstrate the effectiveness of automation.
Business model
Hoopcare sells and licenses its perioperative AI models to three stated buyer groups: hospitals and ambulatory surgery centers, for ASC/outpatient eligibility identification and preoperative workflow; payors, for enforcing medical policy before authorization; and industry and operating-room technology vendors, which can license the validated risk models to embed clinical prediction in their own products. Company communications from the earlier French deployment also describe helping facilities generate revenue by documenting and developing a digital perioperative clinic, referencing French IFAQ programs and preoperative day-hospital program expansion.
Revenue is derived from deployments with hospitals and ambulatory surgery centers, payor arrangements, and licensing of risk models to industry and OR technology partners; earlier French-market materials also reference facility revenue programs tied to the digital perioperative clinic.
Traction
By the end of 2022 the company reported roughly 10,020 preoperative questionnaires completed since January 2022, 65 positive reviews with a 4.8/5 Google rating and 86% of patients reporting being satisfied or very satisfied, five new facilities deployed during 2022 (Centre Hospitalier de Martigues, Ramsay private hospitals Paul d'Égine and Claude Galien, GH Nord-Essonne in Longjumeau, and Hôpital Marie Lannelongue), and a team of 15 people spanning developers, engineers, anesthesiologists, surgeons, nurses and a pharmacist. Automated screening flagged anemia in 10.2% of laboratory results, potential preoperative malnutrition in 2.2% of patients, and 7% of patients were smokers who received assisted nicotine patch prescription support. A contract was signed with Ramsay Santé for a proof of concept at Hôpital Privé Paul d'Égine, and the company participated in a French Article 51 national anemia-management experiment involving more than twenty facilities. A March 2026 report lists 6 employees and total funding of $220,000. The company states eight or more models with development and analysis complete and manuscripts in pre-submission for 2026.
Latest developments
The current platform offers a catalog of eight named models plus 15+ additional outcome predictions delivered inside Epic and Cerner, with eight manuscripts listed as pre-submission for 2026 covering automated chart review, ASC eligibility triage, RBC transfusion volume, hospital and ICU length of stay, LLM-driven morbidity and mortality review, VTE risk, postoperative pain and preoperative AI-ECG ejection fraction. A funding report published 25 March 2026 states Hoopcare raised $220,000 and describes the company as a digital-first preoperative clinic planning to strengthen its technology infrastructure, expand its clinical and engineering team and broaden reach to additional healthcare providers and systems.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Hoopcare targets the perioperative risk-assessment segment of clinical AI, addressing a market the company frames by citing estimates that over 300 million surgical procedures occur annually worldwide, that roughly 10% of surgical patients are high risk and account for about 80% of postoperative deaths, and that postoperative death ranks as a leading cause of mortality globally. A March 2026 funding roundup classifies it as a seed-stage company in the hospitals and health care industry.
Hoopcare positions around a single integrated preoperative platform predicting 20+ outcomes rather than point solutions, validation on a 1.3M+ case cohort, forward-deployed engineers working alongside customer Epic and IT teams, prospective validation of model performance on the customer's own patient population with local anesthesiologists and surgeons, and a stated four-to-six week path from signature to first scored patient. For payors, it claims to be the first system able to enforce medical policy before authorization.
Technology
The model catalog combines gradient-boosted tree models (LGBM, including an LGBM Tweedie model for length of stay) with ResNet deep-learning models applied to 12-lead ECGs. Reported performance includes AUROC ranges of 0.90-0.96 for the Global Risk Score and ASC eligibility, 0.89-0.92 for VTE and ECG-based LVEF prediction, and 0.80-0.85 for ECG-based aortic stenosis and pulmonary hypertension screening, plus mean absolute error of 0.4-0.6 units for RBC prediction and 0.3-0.5 days for length of stay. Models were trained and validated on a de-identified cohort of more than 1.3 million surgical cases. Deployment uses SMART on FHIR integration with Epic and Cerner, can run in the customer's own cloud tenant, and the company states HIPAA compliance with signed BAAs and SOC 2 compliance. Earlier technology included an AI-driven self-completed preoperative questionnaire with automated triage and laboratory result retrieval, and connected-watch remote monitoring.
Go-to-market
Direct enterprise sales to health systems, ASCs and payors via a book-a-call/contact motion on its website, supported by forward-deployed engineering for EHR integration, security review and go-live, and clinical validation with the customer's own clinicians. Model licensing serves industry and OR technology partners. In France the company ran facility-level deployments and proofs of concept with hospital groups, and published newsletters and patient information content; it also plans peer-reviewed publications to support clinical credibility.
Hospitals and ambulatory surgery centers with surgical or obstetric activity, payors, industry and operating-room technology vendors, and the anesthesiologists, surgeons and perioperative clinicians within those organizations; patients are served through the preoperative questionnaire, information center and virtual care management programs.
Geography
Originally deployed in France with hospital and clinic customers, with a French-language site and newsletter; U.S. operations opened with a stated goal of the first Hoopcare USA patient evaluated in February 2023. Current U.S. presence includes a New York phone number, a Techstars Baltimore location listed on the support page, and the affiliated entity Hoopcare Medical of Florida P.A. A March 2026 profile lists headquarters in the United States.
History
Founded in 2019 as Intelligence Anesthesia following its founder's thesis work on preoperative evaluation, the company bootstrapped a prototype and ran validation trials at Hôpital Foch. In March 2022 it raised €1.8 million from Newfund Capital, MACSF and healthcare business angels to scale deployment of its digital platform. During 2022 it deployed at five additional French facilities, grew to a 15-person team, signed a proof-of-concept contract with Ramsay Santé and launched U.S. operations targeting a first U.S. patient evaluation in February 2023. The product subsequently evolved from a digital preoperative clinic and intelligent questionnaire toward a catalog of validated predictive models embedded in Epic and Cerner, with manuscripts in pre-submission for 2026 and a further $220,000 raise reported in March 2026.
Risks & controversies
The company's website states that model performance and availability are pending final locked-cohort analysis and partner authorization and that the models are not for clinical use, and that Hoopcare is not a medical device and has not been evaluated by the FDA. Full model metrics are shared only under NDA, and the supporting manuscripts remain pre-submission rather than peer-reviewed. A December 2022 company newsletter noted revenue was well below its aspirational figure and set a goal of reaching financial break-even in 2023 to ensure survival amid recession conditions.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 2
by search overlapCompanies competing with Hoopcare for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 6
launches, deals, and filingsA funding roundup reported that Hoopcare, described as a digital-first preoperative clinic, raised $220,000, to be used for technology infrastructure, team expansion and broader reach to healthcare providers and systems.
$220K source ↗
Hoopcare raised €1.8 million from venture capital fund Newfund Capital, French healthcare professional insurer MACSF and several healthcare business angels to intensify deployment of its digital platform.
Deployments added during 2022 at C.H. de Martigues, Ramsay private hospitals Paul d'Égine and Claude Galien, GH Nord-Essonne (Longjumeau) and Hôpital Marie Lannelongue.
The company opened U.S. operations with the stated objective of having its first patient evaluated by Hoopcare USA in February 2023.
Hoopcare signed a contract with the Ramsay Santé group for a proof of concept at Hôpital Privé Paul d'Égine, structured as a before/after study of patient indicators (such as transfusion reduction and smoking cessation follow-up) and medico-economic indicators, with a planned Q1 2023 start.
Hoopcare took part in a national Article 51 experiment on preoperative anemia management pathways involving more than twenty facilities.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 7
primary sources listed
- Hoopcarehoopcare.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Hoopcare do?
- Hoopcare builds AI models for preoperative evaluation that predict surgical, anesthetic and perioperative risk inside hospital EHRs.
- Who are Hoopcare's investors?
- Hoopcare's investors include Newfund Capital, Techstars.
- How much funding has Hoopcare raised?
- Hoopcare has disclosed $220K raised across 1 round.
- Where is Hoopcare headquartered?
- Hoopcare is headquartered in Paris, FR.


